Accession Number: | 0001209191-20-032734 |
Date: | 2020-05-27 |
Issuer: | INTRA-CELLULAR THERAPIES, INC. (ITCI) |
Original Submission Date: |
RIGGS RORY B
C/O INTRA-CELLULAR THERAPIES, INC.
430 EAST 29TH STREET
NEW YORK, NY 10016
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-05-27 | deemed execution date | A | 13,767 (a) | common stock 13,767 | $0.00 | 13,767 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of common stock. |
f2 | on may 27, 2020, the reporting person was granted 13,767 restricted stock units, vesting on the first anniversary of the grant date (may 27, 2021). |